Prominent proptosis in childhood thyroid eye disease

被引:0
|
作者
Liu, GT
Heher, KL
Katowitz, JA
Kazim, M
Moazami, G
Moshang, T
Teener, JW
Sladky, J
Volpe, NJ
Galetta, SL
机构
[1] SCHEIE EYE INST,DIV NEUROOPHTHALMOL,PHILADELPHIA,PA
[2] CHILDRENS HOSP PHILADELPHIA,NEUROOPHTHALMOL SERV,PHILADELPHIA,PA 19104
[3] UNIV PENN,SCH MED,PHILADELPHIA,PA 19104
[4] CHILDRENS HOSP PHILADELPHIA,ORBITAL & PLAST SERV,PHILADELPHIA,PA 19104
[5] COLUMBIA PRESBYTERIAN MED CTR,DEPT OPHTHALMOL,NEW YORK,NY 10032
[6] CHILDRENS HOSP PHILADELPHIA,DIV ENDOCRINOL,PHILADELPHIA,PA 19104
[7] CHILDRENS HOSP PHILADELPHIA,DIV NEUROL,PHILADELPHIA,PA 19104
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Orbital signs and symptoms occur in approximately one half of children with Graves disease, but the symptoms are usually minor and limited to the eyelids. Prominent proptosis is uncommon in children with this disorder. Methods: Review of eight children with prominent proptosis associated with thyroid eye disease. Four patients were treated at the Children's Hospital of Philadelphia, the other four at the Columbia Presbyterian Medical Center. Results: At initial presentation, children ranged in age from 3 to 16 years, There were five girls and three boys. Seven of eight children had hyperthyroidism at ophthalmic presentation. Four patients had restrictive myopathy, and all of the seven patients who underwent neuroimaging had extraocular muscle enlargement. Five patients were treated with lubrication, Two underwent orbital fat decompression. One patient had thyroid eye disease and myasthenia gravis. Conclusions: Proptosis in childhood thyroid eye disease usually is associated with a hyperthyroid state. The proptosis may be dramatic, but corneal exposure and restrictive myopathy are seen in only some of the patients. Neuroimaging shows enlarged extraocular muscles. Most children with this complication can be treated conservatively with topical lubrication, but orbital fat decompression may be considered in patients with more advanced conditions.
引用
收藏
页码:779 / 784
页数:6
相关论文
共 50 条
  • [41] Recurrent Thyroid Eye Disease
    Patel, Payal
    Khandji, Joyce
    Kazim, Michael
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2015, 31 (06): : 445 - 448
  • [42] Management of thyroid eye disease
    Bartalena, L
    Marcocci, C
    Tanda, ML
    Pinchera, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (Suppl 2) : S458 - S465
  • [43] An overview of thyroid eye disease
    Colm McAlinden
    Eye and Vision, 1
  • [44] Thyroid eye disease and glaucoma
    Goldberg, I
    JOURNAL OF GLAUCOMA, 2003, 12 (06) : 494 - 496
  • [45] Steroids in thyroid eye disease
    Leibovitch, Igal
    Kakizaki, Hirohiko
    Selva, Dinesh
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 (07): : 657 - 658
  • [46] Noninflammatory Thyroid Eye Disease
    Ugradar, Shoaib
    Rootman, Daniel B.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 35 (05): : 461 - 464
  • [47] Asymmetrical thyroid eye disease
    Rana, Khizar
    Yong, Lee Shien S.
    Garg, Devanshu
    Leyden, James
    Patel, Sandy
    Slattery, James
    Davis, Garry
    Chan, WengOnn
    Selva, Dinesh
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 1003 - 1003
  • [48] Glycosaminoglycans in thyroid eye disease
    Kahaly, G
    Forster, G
    Hansen, C
    THYROID, 1998, 8 (05) : 429 - 432
  • [49] Rituximab for Thyroid Eye Disease
    Silkiss, Rona Z.
    Reier, Alice
    Coleman, Morton
    Lauer, Simeon A.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2010, 26 (05): : 310 - 314
  • [50] An overview of thyroid eye disease
    McAlinden, Colm
    EYE AND VISION, 2014, 1